Literature DB >> 24530778

Low serum level of secreted frizzled-related protein 5, an anti-inflammatory adipokine, is associated with coronary artery disease.

Toru Miyoshi1, Masayuki Doi2, Shinichi Usui3, Mutsumi Iwamoto2, Masahito Kajiya2, Ko Takeda2, Kazumasa Nosaka2, Rie Nakayama2, Keisuke Okawa2, Wataru Takagi2, Kazufumi Nakamura4, Satoshi Hirohata5, Hiroshi Ito4.   

Abstract

OBJECTIVE: Secreted frizzled-related protein 5 (SFRP5) is an anti-inflammatory adipokine that is associated with insulin resistance in animals. To extend these observations to humans, we investigated the association of serum SFRP5 levels in subjects with and without coronary artery disease (CAD).
METHODS: Subjects (n=185, 68±11 years, 79% male) suspected of having CAD were enrolled in the study and were divided into two groups, CAD and non-CAD subjects, according to the results of their coronary angiographies. Serum SFRP5 levels of the subjects were measured by an enzyme-linked immunosorbent assay.
RESULTS: The serum SFRP5 levels in the subjects with CAD were significantly lower than those in the non-CAD subjects (median [interquartile range]: 47.7 [26.6] vs. 52.4 [29.6] ng/mL, respectively; p=0.02). The serum SFRP5 levels significantly correlated with body mass index, the homeostasis model of assessment of insulin resistance, adiponectin levels, and CAD severity. Multivariate logistic regression analysis revealed that a decreased serum SFRP5 level (log transformed) was independently associated with CAD for all subjects (adjusted odds ratio, 0.36; 95% confidence interval, 0.14-0.94; p=0.03).
CONCLUSION: Serum SFRP5 levels are significantly associated with CAD in humans, suggesting that low SFRP5 levels may contribute to CAD.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adipokine; Coronary artery disease; Inflammation; Obesity; Secreted frizzled-related protein 5

Mesh:

Substances:

Year:  2014        PMID: 24530778     DOI: 10.1016/j.atherosclerosis.2014.01.019

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  18 in total

Review 1.  Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.

Authors:  José J Fuster; Noriyuki Ouchi; Noyan Gokce; Kenneth Walsh
Journal:  Circ Res       Date:  2016-05-27       Impact factor: 17.367

2.  Angiotensin II increases secreted frizzled-related protein 5 (sFRP5) expression through AT1 receptor/Rho/ROCK1/JNK signaling in cardiomyocytes.

Authors:  Xin Jin; Bingyan Guo; Jie Yan; Rong Yang; Liang Chang; Yaling Wang; Chenglong Miao; Suyun Liu; Hui Zhang; Yongjun Li
Journal:  Mol Cell Biochem       Date:  2015-07-01       Impact factor: 3.396

3.  Adipocyte-derived SFRP5 inhibits breast cancer cells migration and invasion through Wnt and epithelial-mesenchymal transition signaling pathways.

Authors:  Wenzhong Zhou; Chunmiao Ye; Liang Li; Liyuan Liu; Fei Wang; Lixiang Yu; Fei Zhou; Yujuan Xiang; Yongjiu Wang; Gengshen Yin; Zhongbing Ma; Qinye Fu; Qiang Zhang; Dezong Gao; Shuya Huang; Zhigang Yu
Journal:  Chin J Cancer Res       Date:  2020-06       Impact factor: 5.087

4.  WNT5A-JNK regulation of vascular insulin resistance in human obesity.

Authors:  Melissa G Farb; Shakun Karki; Song-Young Park; Samantha M Saggese; Brian Carmine; Donald T Hess; Caroline Apovian; Jessica L Fetterman; Rosa Bretón-Romero; Naomi M Hamburg; José J Fuster; María A Zuriaga; Kenneth Walsh; Noyan Gokce
Journal:  Vasc Med       Date:  2016-09-28       Impact factor: 3.239

Review 5.  The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus.

Authors:  Ling-Bin Liu; Xiao-Dong Chen; Xiang-Yu Zhou; Qing Zhu
Journal:  Biosci Rep       Date:  2018-07-02       Impact factor: 3.840

Review 6.  Sfrp5/Wnt Pathway: A Protective Regulatory System in Atherosclerotic Cardiovascular Disease.

Authors:  Shan Tong; Qingwei Ji; Yu Du; Xiaogang Zhu; Caizhong Zhu; Yujie Zhou
Journal:  J Interferon Cytokine Res       Date:  2019-06-13       Impact factor: 2.607

Review 7.  Research update on the association between SFRP5, an anti-inflammatory adipokine, with obesity, type 2 diabetes mellitus and coronary heart disease.

Authors:  Di Wang; Yaping Zhang; Chengxing Shen
Journal:  J Cell Mol Med       Date:  2020-01-31       Impact factor: 5.310

8.  High Serum Secreted Frizzled-Related Protein 5 Levels Associates with Early Improvement of Cardiac Function Following ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention.

Authors:  Yu Du; Yingxin Zhao; Yong Zhu; Chenping Hu; Jianwei Zhang; Qingwei Ji; Wei Liu; Hongya Han; Lixia Yang; Dai Zhang; Shan Tong; Zhijian Wang; Yonghe Guo; Xiaoli Liu; Yujie Zhou
Journal:  J Atheroscler Thromb       Date:  2019-02-15       Impact factor: 4.928

9.  Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study.

Authors:  Maren Carstensen-Kirberg; Julia M Kannenberg; Cornelia Huth; Christa Meisinger; Wolfgang Koenig; Margit Heier; Annette Peters; Wolfgang Rathmann; Michael Roden; Christian Herder; Barbara Thorand
Journal:  Cardiovasc Diabetol       Date:  2017-08-29       Impact factor: 9.951

10.  Association of asymptomatic target organ damage with secreted frizzled related protein 5 in the elderly: the Northern Shanghai Study.

Authors:  Jiadela Teliewubai; Bin Bai; Yiwu Zhou; Yuyan Lu; Shikai Yu; Chen Chi; Jue Li; Jacques Blacher; Yawei Xu; Yi Zhang
Journal:  Clin Interv Aging       Date:  2018-03-06       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.